Author, Year | Aim of the study | Identified SDM steps [Number represents the SDM Step as depicted in Fig. 1] | ||||
---|---|---|---|---|---|---|
Quantitative studies | ||||||
Korteland, 2017 | Assess whether the use of patient decision aids result in an improved quality of decision-making in prosthetic heart valve selection compared with standard preoperative care in patients accepted for aortic and mitral valve replacement. | (Decision for TAVI previously made by heart team) Intervention: 3. Information delivery through patient decision aid online tool: information about and comparison of two options (mechanical / biological heart valve) 4. Patient wishes self-assessed through patient decision aid online tool: exploration of personal feelings and preferences regarding the two options Control: usual care | ||||
Dharmarajan, 2017 | Identify patients’ perceptions of their involvement and satisfaction with treatment selection. | (Comparison between SAVR/TAVI (n = 336) group with medical management group (n = 71)) 3. Information: 97% of TAVI/SAVR and 88% of medical management group agreed to strongly agreed that HCP helped better understand their AS. 95% of SAVR/TAVI group and 87% of medical management group agreed to strongly agreed to be given enough information about pros and cons. 5.Decision: 96% of SAVR/TAVI and 85% of medical management group agreed to strongly agreed being involved in the decision | ||||
Anaya, 2019 | Pilot a patient decision aid (DA) which compares mechanical to tissue valve replacement before SAVR | Intervention: DA sent by post mail 3. Information: significant higher conceptual and risk probability knowledge scores in patients that reported using the DA 4. Patient concerns: reoperation (slightly reduced concerns compared to control), severe bleeding and anticoagulants 5. Decision: 50% preferred a tissue valve; 40% being unsure Control: no DA 4.Patient concerns: reoperation, severe bleeding, taking anticoagulants 5. Decision: 67% preferred a tissue valve; 25% being unsure | ||||
Coylewright, 2020 | Determine whether the repeated use of a decision aid (DA) by heart teams is associated with greater SDM, along with improved patient-centered outcomes and clinician attitudes about DAs. | Intervention: Repeated use of DA 3. Information delivery by means of decision aids (comparison of TAVI and medical management) 4. Patient wishes: in 41% of cases the elicitation of values and preferences was made by asking questions similar to “What matters most?” Control: Visits without DA | ||||
Schmied, 2015 | To determine which information sources and decision criteria are important to patients prior to aortic valve surgery. | 3. Information delivery through HCP (no differentiation between pros and cons of various treatment options reported) 4. Patient wishes: improvement of quality of life and prolongation of life | ||||
Korteland, 2015 | Assess among adult patients accepted for aortic valve replacement: (1) experience with current clinical decision-making regarding prosthetic valve selection, (2) preferences for SDM and risk presentation and (3) prosthetic valve knowledge and numeracy. | 3. Information about options: 59% felt they had sufficient knowledge about two options (biological or mechanical valve) | ||||
Sugiura, 2022 | Evaluate elderly symptomatic severe AS patients’ perspectives on their treatment goals and identify factors that influence their treatment choice. | 2. Goal of care: “What do you hope to accomplish by your treatment?“ 77.6% aimed to reduce symptom burden; 68.4% aimed to maintain independence; 62.2% aimed to regain the ability to engage in a specific activity; 58.2% aimed for an improvement of prognosis. 5. Decision: 54.1% reported making the decision based on their values; 52% made a decision based on the wish not to become a burden for the family and 34.7% did not want to become a burden for the society | ||||
Bryssinck, 2021 | Examine post hoc patient satisfaction and the decision-making process of choosing a prosthesis for aortic valve replacement | 3. Information about options: 79.6% felt they were well informed to support their valve choice 4. Patient wishes: 48.7% of the patients believed it is important to be involved in the valve choice 5. Decision: 64.5% of patients stated that the decision was made mainly or only by the HCP and 35.4% stated that the decision was shared between HCP and patient | ||||
Qualitative studies | ||||||
Skaar, 2017 | Explore conditions for an autonomous choice experienced by older adults who recently underwent TAVR, with a special focus on relational and cognitive aspects. | 3. Information delivery through HCP: only communication of risks in case of no intervention 4. Patient wishes: fear of declining/improvement of quality of life 5. Decision: patients reported making the decision on their own; some reported obligation towards relatives to accept treatment recommendation (TAVI) | ||||
Coylewright, 2016 | Elicit and report patient-defined goals from elderly patients facing treatment decisions for severe AS. | 2. Goals of care: “What do you hope to accomplish by having your valve replaced?“ (i) maintaining independence; (ii) staying alive; (iii) reducing/ eliminating pain or symptoms; and (iv) ability to do a specific activity | ||||
Olsson, 2016 | Describe the decision-making process about undergoing TAVI treatment among people with severe aortic stenosis. | 3. Information: 8 patients reported feeling ambivalent (unsure about the diagnosis, benefits or effects of TAVI as well as method) | ||||
Beishuizen, 2021 | Assess patient expectations and goals before TAVI, and determine after treatment whether they had been met. | 2. Goals of care: “What do you hope to accomplish by undergoing this treatment?“ 48.5% aimed to regain the ability to engage in a specific activity; 27.9% aimed to reduce symptom burden; 11.8% aimed to maintain independence. | ||||
Ingle, 2021 | Determine decision needs among patients with symptomatic AS | 3. Information: Patients seeked information about treatment options 4. Patient wishes: Patients expressed experiencing fear as a consequence of not having enough information or because of illness outcomes. 5. Decision: some patients (number n.a.) expressed the importance of including significant others in deliberating about treatment options. Others expressed the preference to leave the decision to the clinician. | ||||
Picou, 2022 | Outline the patient experiences related to AS diagnosis, treatment decisions, self-management, and overall personal feelings and psychological impact of the disease. | 3. Information: Patients expressed relying on their HCP to gather information for the decision-making process. Patients also searched for additional information elsewhere. 4. Patient wishes: Patients reported making decisions based on their own preferences | ||||
Col, 2022 | Identify, prioritize, and organize patient-reported goals and features of treatment for severe AS | 2. Treatment goals: “What are the specific goals that you think are most important to consider when deciding about treating AS?“: have trust in HCP; receive good information; live a long life; reduce future risks; improve quality of life; reduce decisional regret; be independent. 3. Information: 92.6% of the patients rated information about options when replacing or repairing a valve as very important; 85.3% rated information about intra and post operative risks as very important 4. Patient wishes: 65.8% rated a treatment recommendation from the HCP as very important |